Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (81-90 of 464) with videos related to

Pageof 47
Sort By:
Drugs|January 5, 2021
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel DiseaseJurij Hanzel, Christopher Ma, Niels Vande Casteele, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 3, 2019
The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic reviewDan Segal, Paul Marotta, Mahmoud Mosli, et al.
Gastroenterology & Hepatology|November 18, 2022
Case Report: Managing Postoperative Crohn's DiseaseJurij Hanzel, Sudheer Kumar Vuyyuru, Neeraj Narula, et al.
Drugs|August 28, 2021
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel DiseaseJurij Hanzel, Christopher Ma, Niels Vande Casteele, et al.
Journal of Crohn'S & Colitis|August 11, 2021
Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel DiseaseEileen Crowley, Christopher Ma, Marija Andic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2018
Identifying Outcomes in Clinical Trials of Fistulizing Crohn's Disease for the Development of a Core Outcome SetChristopher Ma, Claire E Parker, Tran M Nguyen, et al.
Advances in Therapy|September 10, 2020
The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current EvidenceBrian G Feagan, Mona Marabani, Jashin J Wu, et al.
Inflammatory Bowel Diseases|June 17, 2016
The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane ReviewsReena Khanna, Nilesh Chande, Séverine Vermeire, et al.
Inflammatory Bowel Diseases|October 25, 2011
Therapeutic drug monitoring of biologics for inflammatory bowel diseaseJean-Frédéric Colombel, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|April 18, 2013
Long-term clinical experience with vedolizumab in patients with inflammatory bowel diseaseAsit Parikh, Irving Fox, Timothy Leach, et al.
Pageof 47

Showing results (81-90 of 464) with videos related to

Sort By:
Pageof 47
Drugs|January 5, 2021
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel DiseaseJurij Hanzel, Christopher Ma, Niels Vande Casteele, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|May 3, 2019
The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic reviewDan Segal, Paul Marotta, Mahmoud Mosli, et al.
Gastroenterology & Hepatology|November 18, 2022
Case Report: Managing Postoperative Crohn's DiseaseJurij Hanzel, Sudheer Kumar Vuyyuru, Neeraj Narula, et al.
Drugs|August 28, 2021
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel DiseaseJurij Hanzel, Christopher Ma, Niels Vande Casteele, et al.
Journal of Crohn'S & Colitis|August 11, 2021
Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel DiseaseEileen Crowley, Christopher Ma, Marija Andic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2018
Identifying Outcomes in Clinical Trials of Fistulizing Crohn's Disease for the Development of a Core Outcome SetChristopher Ma, Claire E Parker, Tran M Nguyen, et al.
Advances in Therapy|September 10, 2020
The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current EvidenceBrian G Feagan, Mona Marabani, Jashin J Wu, et al.
Inflammatory Bowel Diseases|June 17, 2016
The Next Wave of Biological Agents for the Treatment of IBD: Evidence from Cochrane ReviewsReena Khanna, Nilesh Chande, Séverine Vermeire, et al.
Inflammatory Bowel Diseases|October 25, 2011
Therapeutic drug monitoring of biologics for inflammatory bowel diseaseJean-Frédéric Colombel, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|April 18, 2013
Long-term clinical experience with vedolizumab in patients with inflammatory bowel diseaseAsit Parikh, Irving Fox, Timothy Leach, et al.
Pageof 47